PRINSTON INC FDA Approval ANDA 075907

ANDA 075907

PRINSTON INC

FDA Drug Application

Application #075907

Documents

Review2005-07-22

Application Sponsors

ANDA 075907PRINSTON INC

Marketing Status

Prescription001

Application Products

001CAPSULE;ORAL12.5MG0HYDROCHLOROTHIAZIDEHYDROCHLOROTHIAZIDE

FDA Submissions

ORIG1AP2002-09-17
LABELING; LabelingSUPPL6AP2011-07-07
LABELING; LabelingSUPPL15AP2022-06-06STANDARD

Submissions Property Types

SUPPL15Null31

TE Codes

001PrescriptionAB

CDER Filings

PRINSTON INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 75907
            [companyName] => PRINSTON INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"HYDROCHLOROTHIAZIDE","activeIngredients":"HYDROCHLOROTHIAZIDE","strength":"12.5MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"HYDROCHLOROTHIAZIDE","submission":"HYDROCHLOROTHIAZIDE","actionType":"12.5MG","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.